PolyPeptide Group AG (PLYGF) Ratios
PolyPeptide Group AG Ratios
PLYGF's free cash flow for Q2 2026 was $-18.47M. For the 2026 fiscal year, PLYGF's free cash flow was decreased by $-43.65M and operating cash flow was $25.18M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.74 | 1.69 | 1.85 | 2.62 | 3.19 |
| Quick Ratio | 0.91 | 0.94 | 1.12 | 1.11 | 2.10 |
| Cash Ratio | 0.40 | 0.35 | 0.54 | 0.39 | 1.31 |
| Solvency Ratio | 0.03 | 0.03 | -0.07 | 0.22 | 0.39 |
| Operating Cash Flow Ratio | 0.42 | 0.46 | 0.21 | 0.06 | 0.55 |
| Short-Term Operating Cash Flow Coverage | 143.41 | 2.92 | 0.88 | 4.98 | 50.09 |
| Net Current Asset Value | $ -160.36M | $ -71.11M | $ 18.74M | $ 97.47M | $ 157.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.12 | 0.16 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.38 | 0.26 | 0.30 | 0.05 | 0.04 |
| Debt-to-Capital Ratio | 0.28 | 0.21 | 0.23 | 0.05 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.24 | 0.10 | 0.11 | 0.02 | 0.02 |
| Financial Leverage Ratio | 2.43 | 2.12 | 1.81 | 1.37 | 1.41 |
| Debt Service Coverage Ratio | 2.40 | 0.57 | -0.32 | 7.93 | 17.83 |
| Interest Coverage Ratio | 0.40 | -0.44 | -5.08 | 3.67 | 22.73 |
| Debt to Market Cap | 0.12 | 0.07 | 0.15 | 0.01 | 0.00 |
| Interest Debt Per Share | 4.51 | 3.37 | 3.67 | 0.75 | 0.65 |
| Net Debt to EBITDA | 1.23 | 0.91 | -0.81 | -0.46 | -1.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.41% | 11.59% | 1.49% | 18.50% | 35.34% |
| EBIT Margin | 1.89% | -1.27% | -16.42% | 3.44% | 22.21% |
| EBITDA Margin | 11.61% | 8.39% | -6.91% | 12.71% | 29.54% |
| Operating Profit Margin | 1.89% | -2.17% | -11.38% | 4.49% | 22.74% |
| Pretax Profit Margin | -5.46% | -5.36% | -18.18% | 2.69% | 21.21% |
| Net Profit Margin | -5.44% | -5.78% | -16.06% | 2.76% | 16.75% |
| Continuous Operations Profit Margin | -5.44% | -5.78% | -16.06% | 2.76% | 16.75% |
| Net Income Per EBT | 99.50% | 107.82% | 88.32% | 102.64% | 78.96% |
| EBT Per EBIT | -288.87% | 246.40% | 159.71% | 60.02% | 93.27% |
| Return on Assets (ROA) | -2.58% | -2.59% | -7.46% | 1.35% | 7.94% |
| Return on Equity (ROE) | -6.26% | -5.48% | -13.49% | 1.84% | 11.22% |
| Return on Capital Employed (ROCE) | 1.16% | -1.31% | -7.11% | 2.63% | 13.07% |
| Return on Invested Capital (ROIC) | 1.14% | -1.23% | -5.77% | 2.65% | 10.45% |
| Return on Tangible Assets | -2.63% | -2.64% | -7.65% | 1.39% | 8.14% |
| Earnings Yield | -2.30% | -1.97% | -8.28% | 0.92% | 1.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.45 | 3.93 | 4.07 | 5.72 | 4.16 |
| Payables Turnover | 4.41 | 4.09 | 5.18 | 4.99 | 6.41 |
| Inventory Turnover | 2.13 | 2.05 | 2.46 | 1.58 | 1.61 |
| Fixed Asset Turnover | 0.85 | 0.87 | 0.99 | 0.95 | 1.20 |
| Asset Turnover | 0.47 | 0.45 | 0.46 | 0.49 | 0.47 |
| Working Capital Turnover Ratio | 2.88 | 2.39 | 2.10 | 1.47 | 1.85 |
| Cash Conversion Cycle | 170.94 | 182.07 | 167.93 | 221.87 | 256.81 |
| Days of Sales Outstanding | 81.93 | 92.96 | 89.75 | 63.84 | 87.70 |
| Days of Inventory Outstanding | 171.75 | 178.40 | 148.62 | 231.24 | 226.09 |
| Days of Payables Outstanding | 82.74 | 89.30 | 70.44 | 73.22 | 56.99 |
| Operating Cycle | 253.68 | 271.37 | 238.37 | 295.09 | 313.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.36 | 2.71 | 1.11 | 0.17 | 1.79 |
| Free Cash Flow Per Share | -0.92 | 0.07 | -0.61 | -2.11 | -0.52 |
| Dividend Paid and CapEx Coverage Ratio | 0.72 | 1.03 | 0.64 | 0.06 | 0.78 |
| Capital Expenditure Coverage Ratio | 0.72 | 1.03 | 0.64 | 0.07 | 0.78 |
| Operating Cash Flow Coverage Ratio | 0.60 | 0.95 | 0.32 | 0.26 | 3.19 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.26 | 0.11 | 0.02 | 0.20 |
| Free Cash Flow Yield | -3.29% | 0.24% | -3.26% | -8.26% | -0.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -43.79 | -51.20 | -12.08 | 108.60 | 89.65 |
| Price-to-Sales (P/S) Ratio | 2.36 | 2.94 | 1.94 | 3.00 | 15.02 |
| Price-to-Book (P/B) Ratio | 2.72 | 2.78 | 1.63 | 2.00 | 10.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -30.38 | 409.26 | -30.69 | -12.11 | -255.09 |
| Price-to-Operating Cash Flow Ratio | 11.85 | 11.13 | 17.03 | 154.48 | 73.87 |
| Price-to-Earnings Growth (PEG) Ratio | -5.17 | 0.82 | 0.02 | -1.30 | 2.17 |
| Enterprise Value Multiple | 21.56 | 35.92 | -28.86 | 23.16 | 49.41 |
| Enterprise Value | 980.74M | 1.02B | 639.29M | 827.16M | 4.12B |
| EV to EBITDA | 21.56 | 35.92 | -28.86 | 23.16 | 49.41 |
| EV to Sales | 2.50 | 3.01 | 2.00 | 2.94 | 14.60 |
| EV to Free Cash Flow | -32.22 | 419.89 | -31.57 | -11.88 | -247.97 |
| EV to Operating Cash Flow | 12.57 | 11.42 | 17.52 | 151.50 | 71.81 |
| Tangible Book Value Per Share | 9.89 | 10.39 | 11.07 | 12.30 | 12.68 |
| Shareholders’ Equity Per Share | 10.31 | 10.85 | 11.57 | 12.78 | 13.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.08 | 0.12 | -0.03 | 0.21 |
| Revenue Per Share | 11.88 | 10.28 | 9.73 | 8.52 | 8.79 |
| Net Income Per Share | -0.65 | -0.59 | -1.56 | 0.24 | 1.47 |
| Tax Burden | 1.00 | 1.08 | 0.88 | 1.03 | 0.79 |
| Interest Burden | -2.89 | 4.22 | 1.11 | 0.78 | 0.95 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.06 | 0.05 | 0.12 | 0.10 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -3.69 | -4.57 | -0.71 | 0.70 | 1.21 |
Currency in EUR